Matthew Porteus
Net worth: 8 M $ as of 29/04/2024
Matthew Porteus active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Stanford School of Medicine | Corporate Officer/Principal | 30/09/2010 | - |
| Stanford University | Corporate Officer/Principal | - | - |
Career history of Matthew Porteus
Former positions of Matthew Porteus
| Companies | Position | Start | End |
|---|---|---|---|
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | 31/01/2003 | 31/07/2010 |
| LENZ THERAPEUTICS, INC. | Director/Board Member | 29/02/2020 | - |
| Founder | 31/05/2017 | - | |
| CRISPR THERAPEUTICS AG | Founder | 30/10/2013 | - |
Training of Matthew Porteus
| Harvard University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistics
International
| United States | 6 |
| Switzerland | 2 |
Operational
| Founder | 3 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Private companies | 1 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Matthew Porteus
- Experience
